Given the important role of extracellular S1P in mediating tumor-associated angiogenesis [19], our findings suggesting an increase in plasma membrane-localized SK2 in GBM as a result of IC1 downregulation suggests that targeting SK2 in GBM may have beneficial antiangiogenic effects. Here, MBTPS1 is linked to glioblastoma.